This HTML5 document contains 72 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q63315663
rdf:type
wikibase:Item
schema:description
клінічне випробування klinisch onderzoek ensayu clínicu clinical trial
rdfs:label
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
skos:prefLabel
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
schema:name
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
p:P1476
wds:Q63315663-4C6C3FAB-6C0F-4CF0-B484-BA4F9330AE89
wdt:P1476
A 12-Week Dose-ranging Study to Evaluate the Efficacy and Safety of Fp Spiromax® (Fluticasone Propionate Inhalation Powder) Administered Twice Daily Compared With Placebo in Adolescent and Adult Subjects With Severe Persistent Asthma Uncontrolled on High Dose Inhaled Corticosteroid Therapy
p:P582
wds:Q63315663-4933CB32-076C-4E2F-B738-2573373D4F96
wdt:P582
2013-07-01T00:00:00Z
p:P31
wds:Q63315663-ECE3EFD3-48D8-4803-84E8-4CFD6FF3DF7B
wdt:P31
wd:Q30612
p:P580
wds:Q63315663-D31680A1-2CA7-4272-A4D9-480260691C94
wdt:P580
2012-04-01T00:00:00Z
p:P17
wds:Q63315663-1B4436C0-8A07-4A0B-8019-39D49C806DBE wds:Q63315663-0DF05925-DA95-46B2-8096-84EA08965C30 wds:Q63315663-134B307E-B655-4B76-BE23-D8BBA9C8B124 wds:Q63315663-4F18B6CE-01E9-4AC6-8885-71681029CA12 wds:Q63315663-E2D823B6-C966-4BC1-86A7-E74CC610907D wds:Q63315663-42F15ED1-4AFF-4482-BE20-A339B449E139 wds:Q63315663-B77D7E8C-0093-48BD-A5CB-72ED66ECCF5A wds:Q63315663-8F28CF3A-B9B0-42D3-991B-15BEEF27467B wds:Q63315663-3C2E100F-2895-474C-A255-2D893686BDA3 wds:Q63315663-9869CF0C-626C-4A6B-ADC6-25DF9F1E17FF wds:Q63315663-225C0C66-23E8-4ABB-AB70-FB871DA5A4EE wds:Q63315663-8B9FC0F4-7674-4988-9C47-A3CCE5CECC14 wds:Q63315663-79EBFD48-629F-4B5F-93DC-A371B6E56283 wds:Q63315663-77042F9D-8482-430C-AB4A-90A231EA646D wds:Q63315663-FA506FE8-D441-4E5C-A92F-65A5173BDA8B wds:Q63315663-5C7069DC-B746-480B-83A8-4C760AD064C1 wds:Q63315663-686C7BAA-5396-4B97-9DBB-3AA5139CBBD8 wds:Q63315663-F939678C-FDC1-4BBA-84BC-3C186F326030
wdt:P17
wd:Q30 wd:Q145 wd:Q219 wd:Q41 wd:Q183 wd:Q664 wd:Q16 wd:Q408 wd:Q27 wd:Q258 wd:Q801 wd:Q224 wd:Q36 wd:Q212 wd:Q29 wd:Q218 wd:Q28 wd:Q403
p:P4844
wds:Q63315663-20E26429-23ED-4475-A31B-5C24858E201A wds:Q63315663-765AD30C-AEE9-49E7-9BA8-DFF1E22942F4 wds:Q63315663-2425C2B2-7ED4-4029-A9E7-1DAF7A769633
wdt:P4844
wd:Q50430229 wd:Q48566653 wd:Q1002165
p:P2899
wds:Q63315663-342209BF-210F-41BC-BCDC-1B130796C747
wdt:P2899
12
p:P1050
wds:Q63315663-6AB95E9A-8D76-4A8F-9E67-35B189F6A38D
wdt:P1050
wd:Q35869
p:P1132
wds:Q63315663-792D6607-7445-447D-8DA1-688E6872DA4E
wdt:P1132
889
p:P8363
wds:Q63315663-0284A043-7182-4D1E-AEE9-86B6333EE249
wdt:P8363
wd:Q78089383
p:P3098
wds:Q63315663-DC50996B-4373-4DD1-B4BC-F25C55B52CE0
wdt:P3098
NCT01576718
p:P6099
wds:Q63315663-7FFF5CEE-FA86-4DB8-AAAC-43FB03A35556
wdt:P6099
wd:Q42824440
p:P8005
wds:Q63315663-74B13E12-A6E2-4A7B-B41F-AAA4B54D10E8
wdt:P8005
wd:Q76651189